IL22RA2 and psoriasis: Both genetic IL-22BP deficiency and anti-IL-22BP neutralizing antibody exacerbated IMQ-induced psoriasis-like skin disease with increased levels of epidermal thickeness and enhanced expression of inflammatory cytokines and IL-22-inducible antimicrobial peptides.